Developments in HIV-1 immunotherapy and therapeutic vaccination.
about
Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptionsProinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressors.The social value of candidate HIV cures: actualism versus possibilism.Cell therapies for treatment of human immunodeficiency virus infection.
P2860
Developments in HIV-1 immunotherapy and therapeutic vaccination.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Developments in HIV-1 immunotherapy and therapeutic vaccination.
@ast
Developments in HIV-1 immunotherapy and therapeutic vaccination.
@en
type
label
Developments in HIV-1 immunotherapy and therapeutic vaccination.
@ast
Developments in HIV-1 immunotherapy and therapeutic vaccination.
@en
prefLabel
Developments in HIV-1 immunotherapy and therapeutic vaccination.
@ast
Developments in HIV-1 immunotherapy and therapeutic vaccination.
@en
P2093
P2860
P356
P1433
P1476
Developments in HIV-1 immunotherapy and therapeutic vaccination.
@en
P2093
Angus Dalgleish
Helen Tanner
Peter Lawrence Smith
P2860
P356
10.12703/P6-43
P577
2014-06-02T00:00:00Z